Retail price of 51 formulations fixed by NPPA Roshni Dhar5 July 2023 2:50 PM ISTThrough a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of the 51 formulations including those...
NPPA Fixes Retail Price Of 51 Formulations, Details Susmita Roy3 July 2023 6:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of the 51 formulations...
First trial over heartburn drug Zantac cancer claims expected in November Ruchika Sharma3 July 2023 2:30 PM ISTNew York: The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state...
Pfizer growth hormone drug Ngenla gets USFDA okay for pediatric patients Ruchika Sharma29 Jun 2023 12:30 PM ISTNew York: Pfizer Inc. and OPKO Health Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla),...
Pfizer application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec accepted by USFDA Ruchika Sharma28 Jun 2023 12:30 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application...
Pfizer scraps once-a-day experimental obesity pill over liver safety concerns Ruchika Sharma27 Jun 2023 2:30 PM ISTNew York: Pfizer Inc said it is scrapping its once-a-day experimental obesity pill because of concerns about liver safety, but will continue...
CDSCO Panel Approves Pfizer's Protocol Amendment Proposal for Marstacimab Dr. Divya Colin25 Jun 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization CDSCO has approved the Protocol amendment...
Hair loss drug: Pfizer Litfulo for adults, adolescents approved by USFDA Ruchika Sharma24 Jun 2023 11:30 AM ISTLITFULO is a kinase inhibitor which inhibits Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) family of...
Pfizer gets USFDA approval for Talzenna, Xtandi combo for prostate cancer treatment Ruchika Sharma21 Jun 2023 12:30 PM ISTTALZENNA (talazoparib) is an oral inhibitor of poly ADP-ribose polymerase (PARP), which plays a role in DNA damage repair.
Pfizer expects to run out of syphilis drug supply for children soon Ruchika Sharma14 Jun 2023 3:34 PM ISTPfizer has warned that a drug used to treat syphilis and other bacterial infections in children could run out by the end of June because it has had to...
Side effects of COVID vaccine: BioNTech faces first German lawsuit Ruchika Sharma12 Jun 2023 10:00 AM ISTThe plaintiff claims she suffered upper-body pain, swollen extremities, fatigue and sleeping disorder due to the vaccine.
Kerala CM holds talks with Pfizer over opening of research centre in Kerala Ruchika Sharma10 Jun 2023 5:04 PM ISTThe Pfizer officials also shared their interest in working with the state's new Digital Science Park, inaugurated recently by Prime Minister Narendra...
